Puberty Suppressing Hormones: Gender Dysphoria
Commons · Question 94872 · Tabled 26 Nov 2025 · Department of Health and Social Care · Official record
Answered 17 Dec 2025
Question
Asked by Rupert Lowe
To ask the Secretary of State for Health and Social Care, what evidence NICE has identified as the basis for its clinical assessment of puberty blockers for gender dysphoria; and whether NICE has undertaken (a) scoping and (b) evaluation exercises since 2
Answer
Answered by Zubir Ahmed, 17 Dec 2025
The National Institute for Health and Care Excellence (NICE) has not developed guidance on, or made a clinical assessment of, puberty blockers for gender dysphoria. In 2020, NICE developed two evidence summaries:Gonadotrophin releasing hormone analogues f...